HENRIQUES RICHARD C JR

CIK 00011811783 companiesBURNABY, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001181178

Recent Transactions

33 trades

Award
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2025-06-09+22,000→ 22,000 total
Disposition to Issuer
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2025-05-19−22,000→ 0 total
Disposition to Issuer
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2025-05-19−22,000→ 0 total
Award
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2025-05-19+22,000→ 22,000 total
Award
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2025-05-19+46,428→ 46,428 total
Award
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2025-05-19+22,000→ 22,000 total
Disposition to Issuer
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2025-05-19−46,428→ 0 total
Award
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2025-05-19+22,000→ 22,000 total
Disposition to Issuer
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2025-05-19−22,000→ 0 total
Award
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2024-06-03+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2024-05-23+67,000→ 67,000 total
Award
Cabaletta Bio, Inc.$CABA
Stock Option (Right to Buy)
2023-06-01+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2023-05-24+55,000→ 55,000 total
Award
Cabaletta Bio, Inc.$CABA
Stock Option (Right to buy)
2022-06-01+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2022-05-25+41,000→ 41,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Options
2021-06-03+22,000→ 22,000 total
Award
Cabaletta Bio, Inc.$CABA
Stock Option (Right to buy)
2021-06-01+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Options
2020-05-28+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Options
2019-08-17+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Director Stock Option (Right to Buy)
2018-06-19+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Director Stock Option Grant (Right to Buy)
2017-06-21+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Director Stock Option (Right to Buy)
2016-06-03+7,500→ 7,500 total
Purchase
Arbutus Biopharma Corp$ABUS
Common Shares
2015-08-24$6.95/sh+1,000→ 1,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2015-08-12+7,500→ 7,500 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (right to buy)
2015-03-30+15,000→ 15,000 total
Award
MERCK SHARP & DOHME LLC
Common Stock
2004-01-15+5,500→ 7,500 total
Sale
MERCK SHARP & DOHME LLC
Common Stock
2003-10-31$44.02/sh−4,100→ 2,000 total
Exercise/Conversion
MERCK SHARP & DOHME LLC
Employee Stock Option - 1995/02/28 (right to buy)
2003-10-31−6,100→ 0 total
Exercise/Conversion
MERCK SHARP & DOHME LLC
Common Stock
2003-10-31$20.08/sh+6,100→ 6,100 total
Sale
MERCK SHARP & DOHME LLC
Common Stock
2003-10-27$45.27/sh−1,000→ 0 total
Sale
MERCK SHARP & DOHME LLC
Common Stock
2003-10-27$45.21/sh−15,000→ 1,000 total
Exercise/Conversion
MERCK SHARP & DOHME LLC
Common Stock
2003-10-27$20.08/sh+15,000→ 16,000 total
Exercise/Conversion
MERCK SHARP & DOHME LLC
Employee Stock Option (right to buy)
2003-10-27−15,000→ 6,100 total

Companies

Recent Filings

Address

C/O TEKMIRA PHARMACEUTICALS CORP. SUITE 100, 8900 GLENLYON PARKWAY

BURNABY, A1, V5J 5J8

View on SEC.gov